-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Ardent Health, Lowers Price Target to $14

Benzinga·12/18/2025 15:27:18
Listen to the news
UBS analyst A.J. Rice maintains Ardent Health (NYSE:ARDT) with a Buy and lowers the price target from $14.5 to $14.